Published in Epidemiol Rev on January 01, 1991
Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci U S A (2001) 4.05
Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis (2008) 3.95
Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest (1994) 3.40
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
Does Helicobacter pylori protect against asthma and allergy? Gut (2008) 2.67
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26
Use of autoradiography to assess viability of Helicobacter pylori in water. Appl Environ Microbiol (1993) 2.16
Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut (1994) 2.14
Infectious agents are not necessary for murine atherogenesis. J Exp Med (2000) 1.85
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
Identification of surface-exposed outer membrane antigens of Helicobacter pylori. Infect Immun (1994) 1.61
Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer (2004) 1.54
High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol Biol Cell (2000) 1.51
Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J Bacteriol (1997) 1.49
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin. J Bacteriol (2006) 1.33
High prevalence of Helicobacter pylori infection in cohabiting children. Epidemiology of a cluster, with special emphasis on molecular typing. Gut (1994) 1.33
Bacterial infection as a cause of cancer. Environ Health Perspect (1995) 1.32
Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol (2013) 1.31
vacA genotypes in Helicobacter pylori strains isolated from children with and without duodenal ulcer in Brazil. J Clin Microbiol (2000) 1.31
Indications for treatment of Helicobacter pylori infection: a systematic overview. CMAJ (1994) 1.27
Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut (1997) 1.24
Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10(-/-) mice. Am J Pathol (1998) 1.24
Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut (2000) 1.24
Comparison of PCR-based restriction length polymorphism analysis of urease genes with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy. J Clin Microbiol (1994) 1.22
Antigenic characterization of Helicobacter pylori strains from different parts of the world. Clin Diagn Lab Immunol (1997) 1.21
Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol (2014) 1.18
Animal and public health implications of gastric colonization of cats by Helicobacter-like organisms. J Clin Microbiol (1994) 1.17
High prevalence of Helicobacter pylori in saliva demonstrated by a novel PCR assay. J Clin Pathol (1995) 1.15
Seroepizootiology of Helicobacter pylori gastric infection in nonhuman primates housed in social environments. J Clin Microbiol (1995) 1.15
Helicobacter pylori: a poor man's gut pathogen? Gut Pathog (2010) 1.14
Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol (2013) 1.14
Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori. Infect Immun (1996) 1.08
Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol (2001) 1.08
A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut (1995) 1.07
Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl Environ Microbiol (2006) 1.06
A highly specific and sensitive DNA probe derived from chromosomal DNA of Helicobacter pylori is useful for typing H. pylori isolates. J Clin Microbiol (1993) 1.06
Spiral bacteria in the human stomach: the gastric helicobacters. Emerg Infect Dis (1996) 1.04
Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect Immun (2003) 1.04
Inactivation of Helicobacter pylori by chlorination. Appl Environ Microbiol (1997) 1.03
Identification of the N-acetylneuraminyllactose-specific laminin-binding protein of Helicobacter pylori. Infect Immun (1997) 1.01
Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun (2003) 1.01
Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control (2012) 1.00
Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. Cancer Epidemiol Biomarkers Prev (2009) 0.97
Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Appl Environ Microbiol (2010) 0.97
Gastric adenocarcinoma and Helicobacter pylori infection. West J Med (1994) 0.95
Gastric tube perforation after esophagectomy for esophageal cancer. Surg Today (2011) 0.95
Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori. Infect Immun (1995) 0.95
Helicobacter pylori cagA status and peptic ulcer disease in Iran. Dig Dis Sci (2008) 0.92
Isolation of Helicobacter strains from wild bird and swine feces. Appl Environ Microbiol (1994) 0.92
Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients. J Clin Pathol (2001) 0.92
Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. Am J Pathol (2002) 0.90
Prevalence of mid-gastrointestinal bleeding in patients with acute overt gastrointestinal bleeding: multi-center experience with 1,044 consecutive patients. J Gastroenterol (2009) 0.90
Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS One (2011) 0.89
Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related? Am J Pathol (2003) 0.89
Knowledge and practice of prechewing/prewarming food by HIV-infected women. Pediatrics (2011) 0.89
Antibiotics taken for other illnesses and spontaneous clearance of Helicobacter pylori infection in children. Pharmacoepidemiol Drug Saf (2009) 0.88
Is helicobacter pylori infection a risk factor for coronary heart disease? ARYA Atheroscler (2012) 0.88
Socioeconomic status and stomach cancer incidence in men: results from The Netherlands Cohort Study. J Epidemiol Community Health (1998) 0.87
Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets. Antimicrob Agents Chemother (1998) 0.87
Is the presence of Helicobacter pylori in dental plaque of patients with chronic periodontitis a risk factor for gastric infection? Can J Gastroenterol (2009) 0.87
Helicobacter pylori infection is not associated with an increased hemorrhagic risk in patients in the intensive care unit. Crit Care (2006) 0.86
Clinical Relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan. J Clin Microbiol (2005) 0.86
Contaminated water as a source of Helicobacter pylori infection: A review. J Adv Res (2013) 0.85
Comparison of different methods to detect Helicobacter pylori in the dental plaque of dyspeptic patients. Clin Oral Investig (2007) 0.85
Agglutination of Helicobacter pylori coccoids by lectins. World J Gastroenterol (2000) 0.85
Significance of infectious agents in colorectal cancer development. J Cancer (2013) 0.85
Ethnicity in relation to incidence of oesophageal and gastric cancer in England. Br J Cancer (2012) 0.84
Indistinguishable cellular changes in gastric mucosa between Helicobacter pylori infected asymptomatic tribal and duodenal ulcer patients. World J Gastroenterol (2009) 0.84
Posttreatment follow-up of Helicobacter pylori infection using a stool antigen immunoassay. Clin Diagn Lab Immunol (2001) 0.84
Comparative transcriptomics of H. pylori strains AM5, SS1 and their hpyAVIBM deletion mutants: possible roles of cytosine methylation. PLoS One (2012) 0.83
Gastric cancer risk after vagotomy. Gut (1994) 0.82
CD8+ T cells are associated with severe gastritis in Helicobacter pylori-infected mice in the absence of CD4+ T cells. Infect Immun (2007) 0.82
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut (1997) 0.82
Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients. Clin Exp Gastroenterol (2011) 0.81
A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to children. Trop Med Int Health (2010) 0.81
Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut (1996) 0.81
Unchanging trend of adenocarcinoma of the esophagus and gastric cardia in Taiwan: a 15-year experience in a single center. Dig Dis Sci (2002) 0.81
How diet and lifestyle affect duodenal ulcers. Review of the evidence. Can Fam Physician (2004) 0.81
Helicobacter pylori infection: approach of primary care physicians in a developing country. BMC Gastroenterol (2009) 0.80
Role of meteorological factors in duodenal ulcer seasonality: a nation-wide, population-based study. J Gen Intern Med (2007) 0.79
Seroepidemiology of Helicobacter pylori infection in hellenic navy recruits. Eur J Epidemiol (2001) 0.79
Immune responses to differentiated forms of Helicobacter pylori in children with epigastric pain. Clin Diagn Lab Immunol (2003) 0.79
13C urea breath test. Gut (1998) 0.79
Helicobacter pylori colonization in Nepal; assessment of prevalence and potential risk factors in a hospital-based patient cohort. BMC Res Notes (2016) 0.78
Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain. J Epidemiol Community Health (1997) 0.78
Comment on: Significant association of serum H. pylori IgG antibody titer with kidney function in renal transplanted patients. J Renal Inj Prev (2013) 0.78
Prevalence of Helicobacter pylori in children and their family members in a district in Turkey. J Health Popul Nutr (2007) 0.78
Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol (2005) 0.77
Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease. Infection (1995) 0.76
Clinical Significance of Peripheral Blood T Lymphocyte Subsets in Helicobacter pylori-Infected Patients. Gastroenterol Res Pract (2012) 0.76
Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis. Gut (2003) 0.76
Helicobacter pylori infection: a seroepidemiological study in Gipuzkoa, Basque Country, Spain. Eur J Epidemiol (1997) 0.76
Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut (1992) 0.76
Enhanced reduction of Helicobacter pylori load in precolonized mice treated with combined famotidine and urease-binding polysaccharides. Antimicrob Agents Chemother (2000) 0.75
Peptic ulcer disease and exposure to domestic pets. Am J Public Health (1999) 0.75
New non-invasive test of gastric acid secretion for use in children. Gut (1993) 0.75
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Campylobacter enteritis. N Engl J Med (1981) 7.98
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis (1985) 2.71
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis (2000) 2.42
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Campylobacter enteritis associated with unpasteurized milk. Am J Med (1979) 2.19
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17
An outbreak of waterborne giardiasis associated with heavy water runoff due to warm weather and volcanic ashfall. Am J Public Health (1983) 2.16
Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis (1993) 2.15
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Cellular fatty acid composition of Campylobacter fetus. J Clin Microbiol (1980) 2.14
Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun (1998) 2.14
Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect (1999) 2.10
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis (1984) 2.04
From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis (1981) 2.04
Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis (1986) 2.04
Allelic Variation within Helicobacter pylori babA and babB. Infect Immun (2001) 2.02
Characteristics of Helicobacter pylori variants selected for urease deficiency. Infect Immun (1992) 2.01
Outbreaks of Campylobacter enteritis in two extended families: evidence for person-to-person transmission. J Pediatr (1981) 2.01
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Campylobacter jejuni outer membrane proteins are antigenic for humans. Infect Immun (1984) 1.99
Identification of type II restriction and modification systems in Helicobacter pylori reveals their substantial diversity among strains. Proc Natl Acad Sci U S A (2000) 1.98
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun (1993) 1.97
Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates. Gastroenterology (1999) 1.96
Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med (1996) 1.96
PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J Clin Microbiol (1994) 1.96
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus. Infect Immun (1985) 1.88
Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status. Infect Immun (1996) 1.88
Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol (2001) 1.87
Identification and purification of a cpn60 heat shock protein homolog from Helicobacter pylori. Infect Immun (1992) 1.87
Detection of Helicobacter pylori gene expression in human gastric mucosa. J Clin Microbiol (1995) 1.86
Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol (1993) 1.85
Acute colitis caused by Campylobacter fetus ss. jejuni. Gastroenterology (1980) 1.83
Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect Immun (1996) 1.81
Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res (1999) 1.81
Overcoming the restriction barrier to plasmid transformation of Helicobacter pylori. Mol Microbiol (2000) 1.81
Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis (1995) 1.81
Comparison of molecular methods for subtyping patients and epidemiologically linked environmental isolates of Legionella pneumophila. J Infect Dis (1988) 1.80
Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology (1984) 1.79
Salmonella typhi: the laboratory as a reservoir of infection. J Infect Dis (1980) 1.78